# Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL

> **NIH NIH G20** · RBHS-NEW JERSEY MEDICAL SCHOOL · 2022 · $1,913,331

## Abstract

Overview of the RBL. The Rutgers RBL is located at 225 Warren Street in Newark, New Jersey. This location 
is within a few blocks of the New Jersey Institute of Technology (NJIT) and the Rutgers – Newark main campuses 
and a seven-minute walk from the Rutgers – New Jersey Medical and Dental School’s campus and the adjoining 
University Hospital. The RBL is physically attached to the International Center for Public Health (ICPH) building. 
The RBL provides > 50% of the BSL3 laboratory and BSL3 vivarium (ABSL3) space to the Rutgers campuses. 
This capacity is augmented by the ICPH building, which also contains additional BSL3 and ABSL3 space that is 
run along with the RBL as a single facility by the RBL Director, Dr. David Alland. The ICPH houses the Public 
Health Research Institute, the Rutgers – New Jersey Medical School Department of Microbiology, Biochemistry 
and Molecular Genetics, and the International Center for Tuberculosis Excellence. A Tuberculosis Clinic is 
situated in clinical space on the ICPH first floor. Together the facilities and activities in the ICPH building support 
and augment research performed in the RBL, and investigators performing high threat pathogen research make 
use of the resources available in the RBL. 
The first floor of the RBL is fully dedicated as an ABSL3 facility, which includes 6 procedure/housing suites 
for rodents and rabbits including housing rooms, custom-designed biosafety enclosures, tissue culture labs, 
procedure rooms, dedicated rooms for aerosol challenge, and a necropsy room. Animal care is supported by per 
diem fees, while most of the animal experiments are performed by scientists who are certified to work in the 
facility and supported by individual NIH grants. A new COVID-19 core within the ABSL3 includes BSL3 trained 
staff who can perform COVID-19 related experiments requiring BSL3 facilities for scientists who are not able to 
work in the BSL3 by themselves. This core is mostly supported by Rutgers University funds, with the intention to 
transition this core to eventually be self-sustaining financially. The second floor of the RBL is split equally 
between BSL3 Lab space and Biosafety Level 2 (BSL2) resident labs and support space, which are headed by 
several faculty members. The new COVID-19 BSL3 core also uses the facilities on the second floor RBL for 
COVID-19 core studies.

## Key facts

- **NIH application ID:** 10631469
- **Project number:** 3G20AI167347-01S1
- **Recipient organization:** RBHS-NEW JERSEY MEDICAL SCHOOL
- **Principal Investigator:** David Alland
- **Activity code:** G20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,913,331
- **Award type:** 3
- **Project period:** 2022-08-22 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10631469

## Citation

> US National Institutes of Health, RePORTER application 10631469, Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL (3G20AI167347-01S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10631469. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*